Arthur Allen

Arthur Allen

Arthur Allen writes about the FDA and the pharmaceutical industry as well as COVID-related topics as a Senior Correspondent for KFF Health News, which first published this report.

A senior patient in a wheelchair

Why the next big hope for Alzheimer’s might not help most Black patients

By: - July 7, 2023

The FDA on Thursday gave full approval to what many scientists and doctors believe is the first drug to show promise of slowing the progression of Alzheimer’s disease. But while patient advocates are celebrating, critics see it as the unfortunate triumph of a flawed theory of the disease’s cause and predict the rollout of the […]